LifeWave Biomedical is developing the CardioConnect® connected health solution that improves the clinical management of patients living with congestive heart failure (CHF) in hospital, ambulatory, and home settings. The solution comprises a small, non-invasive lung sensor that provides an absolute and accurate measurement of lung fluids and respiratory parameters. The sensor is coupled to a smartphone/cloud application that provides insights to improve hospitalization decision support and patient self-management. The expected benefits of the system are reduction of health care costs associated with hospitalization and re-admissions, improvement of patient quality-of-life, and potential extension of life expectancy. While competitive solutions are developing, the LifeWave CardioConnect® solution has a unique value proposition which enables potential dominance over both invasive and non-invasive competitive products. The lung interrogation sensor also has application in respiratory care.